Author:
Shapiro Joel,van Hagen Pieter,Lingsma Hester F.,Wijnhoven Bas P. L.,Biermann Katharina,ten Kate Fiebo J. W.,Steyerberg Ewout W.,van der Gaast Ate,van Lanschot J. Jan B.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study;Annals of Surgical Oncology;2024-01-27
2. ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy;Annals of Surgical Oncology;2024-01-25
3. Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR);Digestive and Liver Disease;2023-12
4. Clinicopathological Characteristics and Survival Outcomes in Patients with Advanced Esophageal Squamous Cell Carcinoma Who Were Intraoperatively Diagnosed Non-Curative;Oncology;2023-11-03
5. Standard versus prolonged intervals to surgery in resectable esophageal cancer: does timing matter?;Annals of Oncology;2023-11